IBNCX
Price
$23.17
Change
+$0.02 (+0.09%)
Updated
May 22 closing price
Net Assets
1.54B
RLBEX
Price
$34.84
Change
+$0.03 (+0.09%)
Updated
May 22 closing price
Net Assets
237.69B
Interact to see
Advertisement

IBNCX vs RLBEX

Header iconIBNCX vs RLBEX Comparison
Open Charts IBNCX vs RLBEXBanner chart's image
Macquarie Balanced Fund
Price$23.17
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets1.54B
American Funds American Balanced R4
Price$34.84
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets237.69B
IBNCX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IBNCX vs. RLBEX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNCX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 238B vs. IBNCX (1.54B). RLBEX pays higher dividends than IBNCX: RLBEX (1.98) vs IBNCX (0.45). IBNCX was incepted earlier than RLBEX: IBNCX (21 years) vs RLBEX (23 years). IBNCX (1.83) is less costly to investors than RLBEX (0.59). IBNCX is a more actively managed with annual turnover of: 73.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than IBNCX: RLBEX (250) vs IBNCX (1000). IBNCX annual gain was more profitable for investors over the last year : 7.06 vs. RLBEX (4.75). RLBEX return over 5 years is better than : 38.04 vs. IBNCX (5.93).
IBNCXRLBEXIBNCX / RLBEX
Total Expense Ratio1.810.59307%
Annual Report Gross Expense Ratio1.830.59310%
Fund Existence21 years23 years-
Gain YTD0.5571.97628%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.54B238B1%
Annual Yield % from dividends0.451.9823%
Returns for 1 year7.064.75149%
Returns for 3 years4.1222.5718%
Returns for 5 years5.9338.0416%
Returns for 10 years-6.3754.30-12%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENN14.660.46
+3.24%
PENN Entertainment
AHH6.82N/A
N/A
Armada Hoffler Properties
INDP0.38N/A
N/A
Indaptus Therapeutics
NBIX119.12-1.44
-1.19%
Neurocrine Biosciences
ZENV1.25-0.06
-4.58%
Zenvia